Published 2022 | Version v1
Publication

Potential feasibility of Atezolizumab-Bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors

Additional details

Created:
February 11, 2024
Modified:
February 11, 2024